FHI 360 launches a social impact investing subsidiary.
Dr. Ayoade Alakija, Nigeria's Chief Humanitarian Coordinator, shares insights with CEO Patrick Fine on humanitarian response challenges.
FHI 360’s strong record of research and programming in HIV supports the goal of epidemic control.
Dr. Timothy Mastro, Chief Science Officer, describes his top picks from the latest published research from FHI 360.
The country is now the first in West Africa to achieve validation of trachoma elimination.
FHI 360 is now engaged in a response to the latest Ebola virus disease outbreak along the Congo River.